Position in ABVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$670,031
-$70,341,872 QoQ
Shares Held
5,028
-99.2% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#187
of 301 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Derivatives in ABVX
reported options exposure · as of Jun 30, 2026CallValue
$106,608
CallShares
800
PutValue
$10,660,800
PutShares
80,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,264,515 across 171 Biotechnology names. ABVX ranks #123 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in ABVX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $670,031 | 5,028 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $10,660,800 | 80,000 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $106,608 | 800 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $1,057,825 | 9,500 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $71,011,903 | 637,736 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $324,886,462 | 2,409,154 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $67,427,500 | 500,000 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $248,362,384 | 2,925,352 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,284,335 | 167,887 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $183,862 | 29,418 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $668,316 | 91,300 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,254,208 | 542,900 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,599,992 | 423,600 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $6,048,900 | 423,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,487,580 | 419,400 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||